< Back to previous page
Researcher
Kevin Punie
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From28 Feb 2017 → Today
Projects
1 - 2 of 2
- Novel biomarkers in the risk stratification, surveillance and treatment of young breast cancer patients and germline carriers of pathogenic variants in TP53.From1 Sep 2020 → 13 Feb 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Relapse in breast and gynaecological cancers.From1 Feb 2019 → 1 Oct 2021Funding: Private funding of national origin - undefined
Publications
1 - 10 of 75
- Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis(2023)
Authors: Lieveke Ameye, Kevin Punie
Pages: 3075 - 3080 - Germline TP53 pathogenic variants and breast cancer: A narrative review(2023)
Authors: Kevin Punie
- Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer(2023)
Authors: Kevin Punie
Pages: 23 - 33 - Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?(2022)
Authors: Kevin Punie
- Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast(2022)
Authors: Liliana Sokol, Maxim De Schepper, Edoardo Isnaldi, Anh-Co Truong, François Richard, Ann Smeets, Ines Nevelsteen, Birgit Weynand, Christine Desmedt, Patrick Neven, et al.
- Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer(2022)
Authors: Kevin Punie
Pages: 127 - 139 - Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets(2022)
Authors: Huiwen Che, Liesbeth Lenaerts, Nathalie Brison, Kris Van Den Bogaert, Ruben Heremans, Agnieszka Wozniak, Christophe Dooms, Els Wauters, Sigrid Hatse, Kevin Punie, et al.
Pages: 1164 - 1176 - Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer(2022)
Authors: Kevin Punie
- Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis(2022)
Authors: Kevin Punie
- Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer(2022)
Authors: Kevin Punie
Pages: 567 - 591